DON'T MISS

Bitcoin Snaps Back to $69K in Short Squeeze — Analysts Warn...

0
Bitcoin surged back near $69,000 on Wednesday, rallying more than 10% from Tuesday's low as crypto markets staged a broad relief rally...
Hot Stocks

Oragenics Positions ONP-002 as Potential First-Ever Pharmacological Treatment for Concussion in...

0
Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, has laid out an ambitious...

CRYPTO NEWS

TECH AND GADGETS

Canaan Inc. (NASDAQ: CAN) Announces New Chief Finance Officer and a...

0
Canaan Inc. (NASDAQ: CAN) received a purchase order from HIVE Blockchains Technology Limited for 4000 bitcoin mining machines. The machines should meet the 272...

TRENDING

LATEST REVIEWS

Hot Of the Press

The State of New York Intends To Be the Crypto Capital...

0
The intent of creating relevant legislation regulating the trading and exchange of crypto assets encountered several encumbrances, and thus most operators want to participate....

STOCK NEWS

Binance Settles on the Suspension of Partnerships and Transactions in Brazil

0
The Central bank of Brazil has introduced new policies that Binance finds uncomfortable in the meantime. Those policies have compelled the global cryptocurrency exchange...

Russia Implements a Legislation That Limits the Number of Cryptocurrency Transactions

0
Russia recently implemented a law limiting the number of cryptocurrencies bought by its citizens following legislation regulating its use. The Ministry of Finance sponsored...

S&P 500 ready for another major drop

0
What goes up must come down. This is the worst drop in market history in terms of magnitude. Yesterday was the largest...

Okcoin Sets Feet In Crypto Traders Market In The Netherlands And Malta After Regulatory...

0
Okcoin, the Cryptocurrency exchange, has decided to set its feet in the broader crypto traders market in the Netherlands and Malta. Okcoin has received...

Citius Pharmaceuticals (NASDAQ: CTXR) Expands Horizons in Lymphoma Treatment

0
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) saw its stock price increase by 8.86% to close at $0.8162 at 4:00 PM EDT. After hours,...

BUSINESS